Phosphodiesterases in Disease, Princeton, NJ, USA
Event Nov 13
This conference emphasizes the importance of Phosphodiesterase in genetic studies. 18 speakers from leading pharmaceutical, biotech, and academic institutions will present their newest research on topics ranging from PDE4 in Inflammatory Diseases, New Roles for PDEs, and PDE5 in Disease. Marco Conti of Stanford University and Miles Houslay of the University of Glasgow headline the impressive round - up of speakers. Dr. Kari Stefansson, Chairman and CEO of deCODE Genetics, will present groundbreaking work on the link between the PDE4 D gene and the risk of stroke.